Drug Profile
Research programme: fast dissolve tablet therapeutics - Samyang
Alternative Names: Methylphenidate fast disolve tablet - Samyang; Orally disintegrating tablet therapeutics - Samyang; Risperidone fast disolve tablet - Samyang; Tacrolimus fast disolve tablet - SamyangLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Isoxazoles; Lactones; Macrolides; Phenylacetates; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action Calcineurin inhibitors; Cytokine inhibitors; Dopamine D2 receptor antagonists; Dopamine release stimulants; Immunosuppressants; Serotonin 2A receptor antagonists; T cell activation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Attention-deficit hyperactivity disorder; Schizophrenia; Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Attention-deficit-hyperactivity-disorder in South Korea (PO, Fast dissolve)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in South Korea (PO, Fast dissolve)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Transplant-rejection in South Korea (PO, Fast dissolve)